Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • New report, The participation equation, uncovers key drivers of patient engagement in clinical trials

    October 16, 2025 | Participant engagement, Patient Voice, clinical trials 

    Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.

    Report fan imager

    CAMBRIDGE, UK – October 16, 2025 – Healthcare communications agency Cuttsy+Cuttsy, in collaboration with the International Society for Patient Engagement Professionals (ISPEP), today announced the release of The participation equation, a comprehensive report exploring what drives participant engagement in modern clinical trials. The research offers a fresh, 360-degree perspective by combining quantitative data from 700 clinical trial participants, alongside in-depth qualitative interviews and industry leader insights.

    The report reveals a significant shift in how people discover clinical trials, with 45% of survey respondents learning about opportunities through social media. This highlights a growing reliance on patients to find trials independently, rather than through healthcare professionals. The findings suggest that while patients are taking charge of their health decisions, more can be done to create proactive and supportive pathways to trial participation.

    The participation equation also establishes a clear link between a participant’s trial experience and their likelihood of completing that trial. The data shows that trial completion rates increase in line with positive experience scores. A key factor in this is the level of support felt from the trial healthcare team; participants who said they ‘definitely’ felt supported had a 92% trial completion rate. The report further emphasises that ongoing and empathetic human connection in combination with high-quality and supportive resources are vital for retention.

    “This report brings forward the experiences of patients who have recently participated in modern trials reflective of today’s research landscape and the growing complexity in the trials landscape” says Alexandra Charge, CEO & Co-Founder of ISPEP. “Their insights go beyond ‘what happened’ to reveal ‘why it mattered’, highlighting where trial processes supported them and where gaps remain.”

    The research provides actionable insights for the industry, by providing credible evidence sources that are aligned with participant preferences to support and improve recruitment, retention, and data quality. By understanding how participants weigh burdens against benefits and what support they truly need, sponsors can move from patient-informed trials to truly patient-ready ones. The report is a call to action for the clinical research community to operationalise patient preference into trial design and delivery.

    Download The participation equation to learn more about the evolving landscape of patient engagement and discover how to better align trial processes with patient needs.

    The full report is available to download here.

    This content was provided by Cuttsy + Cuttsy

    Company Details

    Cuttsy and Cuttsy Logo

    Cuttsy + Cuttsy

    Email
    Website

     Latest Content from  Cuttsy + Cuttsy 

    New report now available: Integrating ‘patient first’ into medicine development

    A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...

    The digital prescription – enhancing the patient experience with technology

    We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.

    Compliance — a driving force for influencing public perceptions of the pharma industry?

    How does compliance play into public perceptions of pharma and why is it important for improving public opinion?

    Another year, another B!

    Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

    Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

    Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

    Clinical trial considerations: Why supporting HCPs matters…

    When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

    Clinical trial considerations: Why diversity matters…

    Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

    Clinical trial considerations: Why digital matters…

    Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

    Clinical trials explained: Why imagery matters…

    Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

    Clinical trials explained: Why health literacy matters…

    Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...